Brainomix, Nanoflex Robotics partner to create AI robotics platform for stroke

2023-10-13
Brainomix, Nanoflex Robotics partner to create AI robotics platform for stroke
Preview
来源: mobihealthnews
Photo: Nicole Hill/Getty Images
British medtech company Brainomix and Switzerland-based remote robotic surgical company Nanoflex Robotics announced the receipt of £400,000 ($420,418) and CHF 400,000 ($443,700), respectively, to co-develop an AI-assisted magnetic navigation system for stroke-related robotic surgical tools.
Innovate UK, the innovation agency in the United Kingdom, and Innosuisse, Switzerland's Innovation Agency, awarded the funds.
Brainomix, spun out of the University of Oxford, creates AI-enabled software to aid in treatment decision-making for stroke, cancer and lung fibrosis.
Nanoflex is a medical robotics company focusing on the treatment of ischemic stroke. The company developed a soft robotics system that inserts guidewires and catheters into the brain. It says its tech can simplify and shorten procedure time while reducing risks associated with assessing the brain for interventional stroke treatment.
Through the partnership, starting in 2024, the companies will combine their technologies to create an AI-assisted navigation tool for devices, such as catheters, as they move through the vascular system.
"The project aims to leverage the power of artificial intelligence to enhance Nanoflex Robotics' cutting-edge magnetic robotic navigation system to be the first system worldwide to enable remote thrombectomy, thus transforming stroke treatment options and helping improve outcomes for patients," Dr. George Harston, chief medical and innovation officer at Brainomix, said in a statement.
THE LARGER TREND
Earlier this year, Brainomix received FDA clearance for its AI-enabled stroke software Brainomix 360 e-ASPECTS, used in stroke patients to measure the extent of early ischemic changes or a reduction or restriction of blood flow in the brain.
In 2021, the company closed a £16 million ($16.8 million) Series B funding round.
Earlier this month, Nanoflex Robotics announced it scored a second grant from the Swiss Innovation Agency, bringing its total grant funding this year to CHF 2.9 million ($3.2 million).
In February, the company also received $12 million in funding in a round led by Ascend Capital Partners with participation from Kinled Holding Ltd and Mountain Labs AG.
Other companies in the robotics healthcare space are California-based Mendaera, which garnered $24 million in Series A funding in August, and Diligent Robotics, which scored $25 million in funding last month to expand the reach of its 'socially intelligent service robots.'
Tags: Brainomix, Nanoflex Robotics, robotics, AI stroke management
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
靶点
-
药物
-
Eureka LS:
全新生物医药AI Agent 覆盖科研全链路,让突破性发现快人一步
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。